chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse refers to a 4 years old patient. The patient's medical history and concurrent conditions were not reported. On 29-JUL-2015, the patient was vaccinated with an improperly stored VARIVAX (Merck) (lot # L001335, expiry date 13-JAN-2017). Concomitant medications were not reported. The outcome was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On unknown dates the patients were vaccinated with improperly stored GARDASIL (Lot# K011562, exp. 08-APR-2017; Lot# L004601, exp. 04-NOV-2016; Lot# K007828, exp. 02-MAR-2017; Lot# K006191, exp. 02-FEB-2017, Lot# was reported as L009964, exp. 13-APR-2017) (dose, route and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected because there was no consent to contact physician.
Approximately 6 hours after vaccination, experienced high fever (tmax 103.0), took tylenol with decrease of fever, also felt palpitations described as his heart was racing all night. Woke up this morning with low grade fever 99.4 and some intermittent palpations which are improving.
C/O vomiting, fever 103, Trembling, shaking Tylenol reduced fever but did not relieve. Advised to continue monitoring temperature, increase fluids and see private MD.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions and allergies were not reported. On 26-SEP-2016, the patient was administered with an expired M-M-R II, subcutaneous in the left arm (lot# K016154, expiration date 24-SEP-2016). There were no concomitant medications reported. No adverse reaction was reported. Additional information has been requested.
received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature excursion) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature excursion). At the time of the report, PRODUCT STORAGE ERROR (received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported .  No treatment medications provided by the reporter.
On 6/12 noticed a few red papular and spread over body next 3 days, scabbed over, itchy.
Woke up with inside of lip busted. Went to take seizure meds and he was a little busy. Complaining of stomach pain and not wanting to eat this morning. Mom did get him to take seizure medication this morning but mentioned that pupils are not evenly dilated and he is little dizzy. Told mom to take patient to ER and she said he has a neurologist. Told mom to get him seen by someone, either neurologist or ER. Mom stated understanding and will call the neurologist to see what they say. Patient was eventually admitted. Mom feels this was the result of the vaccines administered as he had been doing ok prior to this.
I received the covid vaccine on 12/23. Since then I have had a fever, chills, body aches, sore throat, headaches, sinus pressure and have been very fatigued. My symptoms seem to come and go, they are currently less severe, but last night a had a fever of 103.2 with chills and shakes.
I contracted shingles a few days after my first injection. A rash developed around the upper right side of my body front and back and lasted over a month. I saw my physician and she confirmed it was shingles.
Diarrhea; vomiting; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 28-year-old (Non-pregnant) female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EL9264, Expiry date was not reported), via unspecified route of administration in left arm on 03Feb2021 at 17:45 (at age of 28-year) as 2nd dose, single for COVID-19 immunization. The patients medical history was not reported. Patient concomitant medication includes Paracetamol (TYLENOL), (LUPIN) for unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EL1283, Expiry date not reported) via unspecified route of administration in left arm on 13Jan2021 17:45 (at age of 28-year-old) as single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID. On 04Feb2021,13:45 (one day after vaccination), Patient experienced diarrhea and vomiting. No treatment was received for event. The facility where the most recent COVID-19 vaccine administered was hospital. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
Headache, Throat pain, Joint pain, Fever, Chills, Fatigue, Dizziness, Vomiting
On 12-21-2020, after the injection patient states she did not feet well and her right index finger began to hurt right after. She states the right index finger pain started to hurt also on 12-23-2020. She states she will be receiving her second dose on Thursday 01-07-2021.
Information has bene received from a registered nurse and a physician referring to a 4 years old patient of unknown gender. Concurrent conditions and medical history were not reported. On 19-MAR-2015, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (lot# J005693, expire date 07-MAY-2015, dose, route, anatomical location were not reported) (incorrect product storage). No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected since all the follow up has been done.
EMLOYEE STATED SHE FELT LIGHT-HEADED, NAUSEOUS, BLURRED VISION. SHE ALSO MENTIONED SHE HAD NOT EATEN ANYTHING AND USUALLY DOESNT EAT AT WORK DUE TO IBS (IRRITABLE BOWEL SYNDROME) AFTER RESTING AND GIVEN CRACKERS AND WATER SHE FELT MUCH BETTER. FROM THE TIME OF INJECTION TO THE SYMPTOMS SUBSIDING, SYMPTOMS LASTED 40 MIN.
Painful skin rashes, allergic contact dermatitis during a week and I don?t feel better now
Presented with painful urination, Dark urine, Nausea and vomiting, Tingling bilat hands and feet, Back pain, occasional headaches and increase liver enzymes.  + Covid test
had a stronger leg pain when she sat down or laid down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 26Mar2021 (Batch/Lot number: unknown) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Leg pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "had a stronger leg pain when she sat down or laid down".  Additional information: It was reported that for a little less than two years patient had been experiencing leg pain,  and after she received the first dose of the vaccine , that night and the day after she had a stronger leg pain when she sat down or laid down. Caller would like to know if she should get the second dose of the vaccine because she's been hearing about people dying from blood clots with the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
hiccups for last 5 days for sometimes; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history included patient was on hearing aid (ongoing). Concomitant medications were not reported. Patient had hiccups for the last 5 days (Jan2021), not for a while but sometimes may be every 5 or a minute. The outcome of the event hiccups was unknown.   Information on the lot/batch number has been requested.
Developed erythema, tenderness and swelling at the injection site, approx 5cm in diameter. Parents returned to our clinic with concern.
This spontaneous report as received from a registered nurse at prison refers to a patient of unknown age (an inmate). In 2005, the patient was vaccinated with PNEUMOVAX23 (dose, route of administration, lot/batch number not reported). The reporter didn't know if the patient had received PNEUMOVAX23 and then was diagnosed with multiple sclerosis or had been diagnosed with multiple sclerosis and then received PNEUMOVAX23. The reporter was too busy to answer questions for the report. The outcome of event was not reported. The relatedness between PNEUMOVAX23 and event was not reported. Upon internal review, the event of multiple sclerosis was considered as medically significant. The reporter also mentioned that an unknown number of HIV (Human Immunodeficiency Virus) patients were revaccinated with PNEUMOVAX23 one time in 5 years. Additional information has been requested.
After the 18 month immunization, we observed a Swelling in the Wrist of our 18 month daughter 3 days after the vaccination. My elder daughter has been diagnosed with juvenile rheumatoid arthritis and I strongly believe she had a reaction to one of the vaccines as well and think the same is happing now to my younger daughter.
Patient was anxious when arrived. After receiving the vaccine, felt light headed and revealed he has "spells" of anxiety similar to current experience.  Became diaphoretic and needed to lie down.
Employee did not immediately report the adverse reaction to me. When she came in for her second dose for MMR (9/18/17), she reported that she had a bad reaction to the last vaccine. She stated she had a "Knot in my arm and it was red and warm for days." After 30 days, there is still a palpable knot in her arm that measures 9mm X 9mm. Second dose of MMR was not given.
Pt. c/o "nerve pain" going from her neck to her fingers within a week of getting the vaccine.  Pt. also states she has left sided leg and calf pain.  Pt. has taken Advil, Tylenol, Amitriptyline (all ready had on hand), and lidocaine patches.  Pt. contacted her provider who told her to put ice on it.  Pt. reports a history of back surgery.
Client states he started having heart racing about 1 1/2 hours after receiving vaccine (Twinrix) and then developed chest pressure (not pain). Recommended ER evaluation.
I had a fever of 100.5F with a headache, sore throat, a lot of coughing, fatigue. I used a home COVID-19 test that came back positive immediately. I called my PCP's office and had a virtual appointment and was prescribed Paxlovid and started taking it that evening.  I also took Advil to help with the fever. I started feeling better used a home COVID-19 test, tested negative. Then two and a half days later started feeling bad, I used a home COVID-19 test and was positive again. It took four or five days before I started to feel better. I retested with a home COVID-19 test and I am now negative. I feel better with the exception lingering fatigue, an occasional sinus headache.
12/10/10 - pt. experienced difficulty with vision in (R) eye and numbness in (R) side of face. 12/11/10 - E.D. visit; diagnosed with Bell's Palsy - Rx: Prednisone x 7 days and antiviral meds, Lyme test - neg., CT scan, bloodwork - neg.
Weak tired episodes  short of breath episodes  No treatment: Sat down and rested blood pressure normal  Pulse normal  Duration 1 hour for full recovery
FLU-LIKE SYMPTOMS; WHOLE BODY ACHES; CHILLS; HEADACHE; FEVERISH; This spontaneous report received from a patient concerned a 20 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 20-APR-2021, the subject experienced flu-like symptoms. On 20-APR-2021, the subject experienced whole body aches. On 20-APR-2021, the subject experienced chills. On 20-APR-2021, the subject experienced headache. On 20-APR-2021, the subject experienced feverish. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flu-like symptoms, whole body aches, headache, feverish, and chills. This report was non-serious.
stuffy nose; sore throat; fever/burning with 101.8 fever; chills; dose given was the low dose per advise by their physician; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (stuffy nose), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever/burning with 101.8 fever), CHILLS (chills) and OFF LABEL USE (dose given was the low dose per advise by their physician) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 012M20A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included Stroke in January 2021.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, the patient experienced PYREXIA (fever/burning with 101.8 fever), CHILLS (chills) and OFF LABEL USE (dose given was the low dose per advise by their physician). On 02-Dec-2021, the patient experienced NASAL CONGESTION (stuffy nose) and OROPHARYNGEAL PAIN (sore throat). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) from 01-Dec-2021 to 02-Dec-2021 for Adverse event, at an unspecified dose and frequency. On 01-Dec-2021, OFF LABEL USE (dose given was the low dose per advise by their physician) had resolved. At the time of the report, NASAL CONGESTION (stuffy nose), OROPHARYNGEAL PAIN (sore throat) and CHILLS (chills) outcome was unknown and PYREXIA (fever/burning with 101.8 fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Dec-2021, Body temperature: 101.8 (High) 101.8 fever.         No relevant concomitant medications were reported.   This case was linked to MOD-2021-403617 (Patient Link).
Tingling of tongue and stating he felt drunk, light headed and flush. Patient was give 25mg dye free diphenhydramine and sat for an additional 20 minutes. Patient was monitored and feel better and went home with wife. The patient feels the acetic acid in the vaccine caused the reaction because he is allergic to vinegar.
Headache, Myalgia, CoughWheeze, Diarrhea, sore throat, chills, hyperpigmentation, fatigue Narrative:  I received the Pfizer vaccine on 1/5/21. I had the following adverse reactions: headache, sore throat, dry cough, lip hyperpigmentation, chills, extreme fatigue, muscle soreness and diarrhea.
Information has been received from a nurse practitioner concerning a 20 year old female with hypertension and no allergies who on 08-APR-2008 was vaccinated with a first dose of GARDASIL vaccine (yeast) (lot number 659182/1757U) without incidence (injection site and route not reported).  On 11-JUN-2008 the patient was vaccinated with a second dose of GARDASIL vaccine (yeast) (lot number 660391/0063X) 0.5 ml intramuscularly in the left arm. Concomitant therapy included vitamins (unspecified), citalopram hydrobromide (CELEXA) and lisinopril (manufacturer unknown). A week later the patient vomited once (but also mentioned that it was hot at her work and the air conditioner was not working). The patient also complained of a hard sore area at the injection site. The reporter mentioned that the area was about the size of a dime and dark purple in color. "It looks like a bruise." There was no fever, rash or redness noted at the site. Unspecified medical attention was sought. At the time of reporting, the patient was recovering from all the symptoms. Additional information has been requested. This is in follow-up to report(s) previously submitted on 7/15/2008.  Follow-up information was received from a registered nurse which reported that the patient returned to the office on 27-JUN-2008 for check of her arm.  There were lump and some dislocation where vaccine was given.  The patient was given TYLENOL and IBUPROFEN as needed.  The patient was recovered from all the events.  Additional information is not expected.
Mom states that child has been having loose stools since vaccines given; having small/medium stools every time he eats (around 9/day). Denies any blood or mucous in the stools. Had a little fever (99.3 - rectal) on Tuesday, 2/6 - treated with TYLENOL and has been afebrile since.
Information has been received from a licensed visiting nurse concerning a 16 year old female patient with asthma, allergic rhinitis, no drug reactions or allergies and a history of uterine bleeding, who on 21-JUN-2011 was vaccinated with the first dose of GARDASIL intramuscularly (Lot number 1017Z). No other vaccines were administered concomitantly. Concomitant therapy included FLONASE, ADVAIR and albuterol (manufacturer unknown). The licensed visiting nurse reported that on 21-JUN-2011, later that day the patient developed headache, dizziness, nausea, vomiting, weakness for two days and sleepiness. On 24-JUN-2011 the patient was seen by a physician at a health center and he recommended that the patient received no more GARDASIL vaccinations. No lab diagnostics studies were performed. TYLENOL was given as a treatment for the experience. At the time of the report, the patient had fully recovered (date not provided). Headache, dizziness, nausea, vomiting, weakness for two days and sleepiness were considered to be temporarily disabling by the licensed practical nurse since the patient missed days of school. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "chronic lyme" (unspecified if ongoing). Concomitant medication(s) included: TETRACYCLINE; BACTRIM DS; CANDESARTAN; AMLODIPINE. Past drug history included: Blueberries for allergy. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that patient received other medication in 2 weeks. COVID 19 Treatment start date was 22May2023 and treatment stop date was 26May2023,  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
No additional adverse event was reported; Medical Assistant calling in to report a temperature excursion of GARDASIL 9. Medical Assistant reported that the GARDASIL 9 was administered to a patient on 06/09/2022..; This spontaneous report was received from a medical assistant, concerning a 18-year-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided.   On 09-JUN-2022, the patient was vaccianted with an improperly stored rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (strenght, dose, frequency, route of administration, lot number and expiration date were not provided). No adverse event was reported.   The temperature excursion was not provided nor if there was a previous temperature excursion.
Information has been received from a physician who received a fax from a patient, concerning a female patient who on an unspecified date was vaccinated with Gardasil. Subsequently, following vaccination, the patient became dizzy, her "muscles were heavy", and she lost focus. It was reported that a nurse sat the patient down, however sitting down did not make the symptoms any better. The physician then came into the room and gave the patient a shot of Benadryl. After receiving the Benadryl the patient was placed in another room for a short time. After a couple of minutes, the nurse went back into the room to take the patient's blood pressure and found the patient having a grand mal seizure. The physician again entered the room and found the patient unconscious, not breathing, and her jaw was clamped and her lips were blue. The patient was subsequently hospitalized. At the time of this report, the outcome of the events was unknown. Additional information has been requested.
Pt experienced a probable systemic reaction to the Anthrax vaccine series, including, chronic fatigue, reduced stamina, muscle pain, impaired concentration, memory, orthostasis, sleep disturbance, GI upset, hypogonadism.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. On 19-FEB-2016 the patient was administered an expired dose of the M-M-R II (lot # K000255, expiration date: 08-JAN-2016, subcutaneous, dose was unknown) (expired product administered). The patient had no known adverse effect at the reporting time. Additional information has been requested.